Estrogenic Activity of Derris scandens Stem Extract and its Major Compounds Using MCF-7 Cell Proliferation Assay and Estrogen-Related Gene Expression
Planta Medica · 2024-08 · 90 (10) · 766-773
DOI: 10.1055/a-2328-2750 ↗Kurz gefasst
Fachartikel in der Zeitschrift Planta Medica, online erschienen am 28.06.2024. Verfasst von Worapol Sae-Foo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen, Thailand. Hauptthemen laut MEDLINE: Cell Proliferation, Plant Extracts, Derris, Isoflavones. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: National Research Council of Thailand.
Abstract (Originalsprache)
Derris scandens, which contains isoflavones and prenylated derivatives, has analgesic and anti-inflammatory properties and is an ingredient in traditional Thai medicine for perimenopause and menopause. However, the estrogenic activity of D. scandens has not yet been explored. Therefore, this study aimed to examine the estrogenic activity of the stem extract of D. scandens and its isoflavone derivatives. In this study, we conducted a proliferation assay in MCF-7 cells, and used quantitative reverse transcription polymerase chain reaction to assess gene expression. We found that the relative cell proliferation of the compounds (1 µM) was ranked in the following order as compared to 0.1 nM 17β-estradiol (100%): genistein (97.84%) > derrisisoflavone A (83.17%) > genistein-7-O-[α-rhamnopyranosyl-(1 → 6)-glucopyranoside] (69.55%) > 6,8-diprenylgenistein (51.91%) > lupalbigenin (18.72%). Furthermore, cotreatment with 1 µM lupalbigenin and 0.1 nM 17β-estradiol was performed, which decreased cell proliferation to 80.38%. In vitro results suggest that lupalbigenin has an estrogen-antagonistic effect. At a dose of 1 µM, genistein had the strongest efficacy in increasing the expression of human estrogen receptor β by 4.0-fold compared to the control. Furthermore, genistein-7-O-[α-rhamnopyranosyl-(1 → 6)]-β-glucopyranoside augmented the gene expression of human estrogen receptor α and human estrogen receptor β by 1.5- and 3.4-fold, respectively. Prenylated derivatives of genistein (derrisisoflavone A, 6,8-diprenylgenistein, and lupalbigenin) significantly suppressed the gene expression of the human androgen receptor. The administration of the crude extract at 10 µg/mL significantly suppressed human androgen receptor (0.6-fold) and transmembrane protease serine 2 (0.1-fold) expression but did not significantly affect human estrogen receptor α and human estrogen receptor β gene expression. This herbal medicine may be safe for estrogen-exposed breast cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen, Thailand.
- School of Pharmacy, Walailak University, Nakhon Si Thammarat, Thailand.
ORCID-Profile: Waraporn Putalun
Förderung
- National Research Council of Thailand
Zitieren
APA
Sae-Foo, W., Yusakul, G., Nualkaew, N., & Putalun, W. (2024). Estrogenic Activity of Derris scandens Stem Extract and its Major Compounds Using MCF-7 Cell Proliferation Assay and Estrogen-Related Gene Expression. Planta Medica, 90(10), 766-773. https://doi.org/10.1055/a-2328-2750
Vancouver
Sae-Foo W, Yusakul G, Nualkaew N, Putalun W. Estrogenic Activity of Derris scandens Stem Extract and its Major Compounds Using MCF-7 Cell Proliferation Assay and Estrogen-Related Gene Expression. Planta Medica. 2024;90(10):766-773. doi:10.1055/a-2328-2750
BibTeX
@article{SaeFoo2024,
author = {Sae-Foo, Worapol and Yusakul, Gorawit and Nualkaew, Natsajee and Putalun, Waraporn},
title = {Estrogenic Activity of Derris scandens Stem Extract and its Major Compounds Using MCF-7 Cell Proliferation Assay and Estrogen-Related Gene Expression},
journal = {Planta Medica},
year = {2024},
volume = {90},
number = {10},
pages = {766--773},
doi = {10.1055/a-2328-2750}
}
EUVIMED